Precision Health and Diagnostics
Symposium Chair
Prakash D. NallathambyAssociate Director of Research at the Berthiaume Institute for Precision Health
University of Notre DameKey Speakers
Automated AI-supported microscopy and portable qPCR for the diagnosis of Plasmodium falciparum and Plasmodium vivax malariaCristian KoepfliAssistant Professor,
University of Notre Dame
Breakthrough Total Body Fluid Monitoring system based on non invasive, non contact RF TechnologyCassandra AdamsCo-Founder & COO,
Vital ViewPrecision health and diagnostics has revolutionized treatment regimens by replacing them with ones that are more effective, less toxic, and positively impact survival.
In efforts to improve the efficacy of diagnostic assays and therapeutic agents, precise molecular recognition of disease-specific markers remains a major hurdle. Achieving only ‘On-Target’ therapeutics will also require technologies beyond this one-size-fits all approach. Innovations in the development of instrumentation, imaging modalities, and spectroscopic techniques support and empower these approaches, enabling bias-free routes to achieve a holistic understanding and treatment of disease states with spatiotemporal precision. Point-of-use platforms seek to bring bioanalytical assays to the individual, thus enhancing the speed with which results are available to caregivers, to exert rapid changes in treatment regimens, to benefit their patients’ health and wellness. Seminal advances in the miniaturization of instrumentation has led to a growing range of smart, accurate, and low-powered, portable biomolecular diagnostics with the ultimate goal of rendering sensors capable of personalized bioassays supporting therapies targeted to the individual.
This session aims to highlight nanotechnology-enabled precision therapeutics/therapies or nanotechnology-based analytical platforms to guide treatment regimen, to benefit all populations.
Back to Top ↑2024 Symposium Sessions |
| Tuesday June 18 |
| 9:15 | Precision Health & Diagnostics |
| 4:00 | Precision Health & Diagnostics - Posters |
|
2024 Symposium Program |
| Tuesday June 18 |
|
| 9:15 | Precision Health & Diagnostics | TBA |
| Session chair: Prakash Nallathamby, University of Notre Dame, US |
| Breakthrough Total Body Fluid Monitoring system based on non invasive, non contact RF Technology
C. Rauh, C. Adams, Vital View, US |
| Point-of-use multiomics diagnosis for accurate and timely precision diagnosis
R. Khosravi-Far, B. Griffith, C. Brown, H. Gamage, InnoTech Precision Medicine, Inc, US |
| Portable device for rapid identification of locally sourced phage for use in phage therapy
S.V. Angus, B. Swan, C. Stewart, A.S. Cowan, Guild Associates, Inc., US |
| Non-Invasive Health Tracking for Optimal Performance & Recovery
G. Travish, ViBo Health, US |
| Automated AI-supported microscopy and portable qPCR for the diagnosis of Plasmodium falciparum and Plasmodium vivax malaria
C. Koepfli, University of Notre Dame, US |
| Nanoparticle Platform Technologies to Circumvent Therapeutics Resistance in Diseases
P.D. Nallathamby, M. Waters, J. Hopf, P. Helquist, University of Notre Dame, US |
|
| 4:00 | Precision Health & Diagnostics - Posters | Expo Hall BC |
| Discriminating Acute versus Chronic Brain Injury in Geriatric Subjects: Results from the HeadSMART Geriatric Feasibility Study.
T.E. Van Meter, N. Mirshahi, S. Boyd, D. Sandsmark, K. Roscovsky, J. Weppner, J. Leinmueller, M. Barton, R. Diaz-Arrastia, and D.R. Kuehl, BRAINBox Solutions, Inc., US |
| Innovative use of RF Polarization Mode Dispersion Technology to create non invasive, non contact Sensors
C. Rauh, C. Adams, Vital View Technologies, US |
| Exploring Serum Biomarkers for Neurological Complications of Systemic Illnesses: Insights from COVID-19 and Beyond
D. Plantone, D. Righi, C. Manco, N. De Stefano, University of Siena, IT |
|
Topics & Application Areas
- Precision therapeutics (to avoid off-target toxicity)
- Precision diagnostics (improved time to decision, improved confidence, improved detection)
- Precision biomedical imaging (in vitro or in vivo)
- Portable Point-of-use platforms for diagnostics (can be for monitoring human health or for monitoring environmental factors that will affect human health)
- Sensors (can be for monitoring human health monitoring or for monitoring environmental factors that will impact human health, SMART sensors)
